Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Recenti Progressi in Medicina|December 20, 2021
[Immunotherapy with nivolumab and pembrolizumab in unresectable or metastatic advanced melanoma: real-life observational study of drug use.]Felice Musicco, Chiara Fulgenzio, Antonia La Malfa, et al.Journal of Clinical Medicine|June 13, 2025
Trends of Anogenital Warts: A 32-Year Retrospective Observational Study (Italy, 1991-2022)Eugenia Giuliani, Maria Gabriella Donà, Mauro Zaccarelli, et al.Antibiotics (Basel, Switzerland)|April 30, 2021
Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control StudyChiara Fulgenzio, Marco Massari, Giuseppe Traversa, et al.Antibiotics (Basel, Switzerland)|June 24, 2022
Effect of Fluoroquinolone Use in Primary Care on the Development and Gradual Decay of Escherichia coli Resistance to Fluoroquinolones: A Matched Case-Control StudyPeter Konstantin Kurotschka, Chiara Fulgenzio, Roberto Da Cas, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 1, 2026
Real-world evaluation of health-related quality of life in hematology patients treated with rituximab: results of a multicentric cross-sectional cohort studySilvana A M Urru, Flavia Mayer, Stefania Spila Alegiani, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 27, 2024
A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in ItalyFelice Musicco, Chiara Fulgenzio, Antonia La Malfa, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|July 29, 2022
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductionsFelice Musicco, Ruggero Lasala, Fiorenzo Santoleri, et al.Global & Regional Health Technology Assessment|October 14, 2024
Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian studyFiorenzo Santoleri, Paolo Abrate, Laura Pestrin, et al.Immunotherapy|April 23, 2024
Adherence, persistence and treatment switching in psoriasisFiorenzo Santoleri, Felice Musicco, Chiara Fulgenzio, et al.Current Medical Research and Opinion|November 23, 2023
ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in ItalyFiorenzo Santoleri, Ruggero Lasala, Paolo Abrate, et al.Pageof 1